Table 2 Hazard ratios (HR) with 95 % confidence intervals (CI) for hepatocellular carcinoma (HCC) among 4270a study subjects, according to HCV RNA-positivity and FIB-4 index. Naples, 2003–2012
HCV RNA | FIB-4 <1.45 | FIB-4 1.45–3.25 | FIB-4 >3.25 | ||||||
|---|---|---|---|---|---|---|---|---|---|
Subjects No. | HCC cases No. (%) | HRb (95 % CI) | Subjects No. | HCC cases No. (%) | HRb (95 % CI) | Subjects No. | HCC cases No. (%) | HRb (95 % CI) | |
Negative | 3380 | 1 (0.03) | 1* | 604 | 0 (0.0) | 0 (0-∞) | 47 | 1 (2.1) | 79.5 (4.9–1285) |
Positive | 61 | 0 (0.0) | 0 (0-∞) | 110 | 3 (2.7) | 99.5 (10.3–957.3) | 68 | 12 (17.6) | 771.2 (100.0–5949) |